ArticleScientific reports2016

PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients.

Hye Ryun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.